$RMD
RESMED INC

2020 Q2 Form 10-Q Financial Statement

#000094381920000008 Filed on May 01, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2020 Q1 2019 Q1
Revenue $770.3M $769.5M $662.2M
YoY Change 9.26% 16.19% 11.93%
Cost Of Revenue $321.0M $319.8M $281.3M
YoY Change 6.12% 13.7% 13.71%
Gross Profit $449.4M $449.7M $381.0M
YoY Change 11.68% 18.03% 10.65%
Gross Profit Margin 58.34% 58.44% 57.53%
Selling, General & Admin $165.4M $172.4M $164.5M
YoY Change -3.61% 4.81% 11.25%
% of Gross Profit 36.8% 38.35% 43.19%
Research & Development $52.50M $51.45M $47.61M
YoY Change 2.74% 8.06% 27.18%
% of Gross Profit 11.68% 11.44% 12.5%
Depreciation & Amortization $38.60M $39.26M $41.70M
YoY Change -9.39% -5.84% 41.84%
% of Gross Profit 8.59% 8.73% 10.95%
Operating Expenses $226.1M $232.2M $224.0M
YoY Change -2.04% 3.65% 7.73%
Operating Profit $223.3M $217.5M $157.0M
YoY Change 30.13% 38.56% 15.11%
Interest Expense -$14.90M $9.968M $12.41M
YoY Change -20.32% -19.7% 60.81%
% of Operating Profit -6.67% 4.58% 7.91%
Other Income/Expense, Net $3.800M -$25.85M -$19.05M
YoY Change -157.58% 35.68% 205.75%
Pretax Income $212.1M $191.7M $137.9M
YoY Change 121.4% 38.95% 5.98%
Income Tax $34.30M $28.52M $32.51M
% Of Pretax Income 16.17% 14.88% 23.57%
Net Earnings $177.8M $163.1M $105.4M
YoY Change 158.43% 54.76% -4.28%
Net Earnings / Revenue 23.08% 21.2% 15.92%
Basic Earnings Per Share $1.13 $0.74
Diluted Earnings Per Share $1.217M $1.12 $0.73
COMMON SHARES
Basic Shares Outstanding 144.7M 144.6M 143.3M
Diluted Shares Outstanding 145.7M 144.3M

Balance Sheet

Concept 2020 Q2 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $463.2M $352.9M $146.5M
YoY Change 214.89% 140.89% -79.2%
Cash & Equivalents $463.2M $352.9M $146.5M
Short-Term Investments
Other Short-Term Assets $159.3M $194.7M $114.4M
YoY Change 44.42% 70.19% 1.24%
Inventory $416.9M $358.8M $319.9M
Prepaid Expenses
Receivables $474.6M $554.9M $511.4M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.523B $1.470B $1.103B
YoY Change 33.01% 33.29% -31.27%
LONG-TERM ASSETS
Property, Plant & Equipment $417.3M $397.2M $382.5M
YoY Change 7.71% 3.85% -3.9%
Goodwill $1.890B $1.884B $1.939B
YoY Change 1.82% -2.82%
Intangibles
YoY Change
Long-Term Investments $14.11M $50.10M $49.15M
YoY Change -34.88% 1.94% 19.43%
Other Assets $148.7M $140.6M $125.7M
YoY Change -1.52% 11.79% -43.54%
Total Long-Term Assets $3.064B $3.041B $2.996B
YoY Change 3.43% 1.5% 55.24%
TOTAL ASSETS
Total Short-Term Assets $1.523B $1.470B $1.103B
Total Long-Term Assets $3.064B $3.041B $2.996B
Total Assets $4.587B $4.511B $4.099B
YoY Change 11.68% 10.05% 15.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $135.8M $116.1M $124.5M
YoY Change 17.34% -6.68% 41.12%
Accrued Expenses $270.4M $235.2M $191.1M
YoY Change 1.5% 23.06% -1.22%
Deferred Revenue $98.62M $97.11M $82.29M
YoY Change 11.22% 18.01%
Short-Term Debt $11.99M $11.99M $12.35M
YoY Change -0.04% -2.91%
Long-Term Debt Due $12.00M $12.00M $12.30M
YoY Change 0.0% -2.44%
Total Short-Term Liabilities $602.8M $551.5M $463.0M
YoY Change 8.41% 19.13% 0.32%
LONG-TERM LIABILITIES
Long-Term Debt $1.164B $1.365B $1.323B
YoY Change -7.53% 3.14% 63.37%
Other Long-Term Liabilities $8.347M $7.527M $865.0K
YoY Change 305.59% 770.17% -99.53%
Total Long-Term Liabilities $1.488B $1.703B $1.614B
YoY Change 0.55% 5.47% 62.56%
TOTAL LIABILITIES
Total Short-Term Liabilities $602.8M $551.5M $463.0M
Total Long-Term Liabilities $1.488B $1.703B $1.614B
Total Liabilities $2.090B $2.254B $2.077B
YoY Change 2.7% 8.52% 41.58%
SHAREHOLDERS EQUITY
Retained Earnings $2.833B $2.712B $2.421B
YoY Change 16.28% 12.02%
Common Stock $1.571B $1.534B $1.476B
YoY Change 3.92% 3.92%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.623B $1.623B $1.623B
YoY Change 0.0% 0.0%
Treasury Stock Shares $41.84M $41.84M $41.84M
Shareholders Equity $2.497B $2.256B $2.021B
YoY Change
Total Liabilities & Shareholders Equity $4.587B $4.511B $4.099B
YoY Change 11.68% 10.05% 15.97%

Cashflow Statement

Concept 2020 Q2 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income $177.8M $163.1M $105.4M
YoY Change 158.43% 54.76% -4.28%
Depreciation, Depletion And Amortization $38.60M $39.26M $41.70M
YoY Change -9.39% -5.84% 41.84%
Cash From Operating Activities $330.3M $239.7M $139.6M
YoY Change 132.77% 71.7% -6.37%
INVESTING ACTIVITIES
Capital Expenditures -$21.10M -$32.20M -$17.00M
YoY Change -12.81% 89.41% 12.58%
Acquisitions
YoY Change
Other Investing Activities $17.80M -$67.50M -$208.5M
YoY Change -190.82% -67.63% 4533.33%
Cash From Investing Activities -$3.400M -$99.70M -$225.4M
YoY Change -92.26% -55.77% 1050.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -236.4M 18.40M 83.20M
YoY Change 142.21% -77.88% -130.09%
NET CHANGE
Cash From Operating Activities 330.3M 239.7M 139.6M
Cash From Investing Activities -3.400M -99.70M -225.4M
Cash From Financing Activities -236.4M 18.40M 83.20M
Net Change In Cash 90.50M 158.4M -2.600M
YoY Change 22525.0% -6192.31% -98.23%
FREE CASH FLOW
Cash From Operating Activities $330.3M $239.7M $139.6M
Capital Expenditures -$21.10M -$32.20M -$17.00M
Free Cash Flow $351.4M $271.9M $156.6M
YoY Change 111.56% 73.63% -4.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Entity Address Country
EntityAddressCountry
US
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-15317
dei Entity Registrant Name
EntityRegistrantName
ResMed Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0152841
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q2 us-gaap Preferred Stock Value
PreferredStockValue
dei Entity Address Address Line1
EntityAddressAddressLine1
9001 Spectrum Center Blvd.
dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92123
dei City Area Code
CityAreaCode
858
dei Local Phone Number
LocalPhoneNumber
836-5000
dei Security12b Title
Security12bTitle
Common Stock, par value $0.004 per share
dei Entity Central Index Key
EntityCentralIndexKey
0000943819
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Trading Symbol
TradingSymbol
RMD
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
144668429
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
352861000
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
147128000
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
28833000
CY2019Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
25171000
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
554859000
CY2019Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
528484000
CY2020Q1 us-gaap Inventory Net
InventoryNet
358772000
CY2019Q2 us-gaap Inventory Net
InventoryNet
349641000
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
203266000
CY2019Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
120113000
CY2020Q1 us-gaap Assets Current
AssetsCurrent
1469758000
CY2019Q2 us-gaap Assets Current
AssetsCurrent
1145366000
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
397209000
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
387460000
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
126277000
CY2020Q1 us-gaap Goodwill
Goodwill
1884458000
CY2019Q2 us-gaap Goodwill
Goodwill
1856449000
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
464963000
CY2019Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
521950000
CY2020Q1 us-gaap Deferred Income Taxes And Other Assets Noncurrent
DeferredIncomeTaxesAndOtherAssetsNoncurrent
27321000
CY2019Q2 us-gaap Deferred Income Taxes And Other Assets Noncurrent
DeferredIncomeTaxesAndOtherAssetsNoncurrent
45478000
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
140557000
CY2019Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
150979000
CY2020Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
3040785000
CY2019Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
2962316000
CY2020Q1 us-gaap Assets
Assets
4510543000
CY2019Q2 us-gaap Assets
Assets
4107682000
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
116148000
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
115725000
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
235201000
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
266359000
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
22795000
CY2020Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
97110000
CY2019Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
88667000
CY2020Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
68278000
CY2019Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
73248000
CY2020Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
11987000
CY2019Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
11992000
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
551519000
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
555991000
CY2020Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
84615000
CY2019Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
81143000
CY2020Q1 us-gaap Deferred Income Taxes And Other Tax Liabilities Noncurrent
DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
25441000
CY2019Q2 us-gaap Deferred Income Taxes And Other Tax Liabilities Noncurrent
DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
11380000
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
107251000
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7527000
CY2019Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2058000
CY2020Q1 us-gaap Long Term Debt
LongTermDebt
1364849000
CY2019Q2 us-gaap Long Term Debt
LongTermDebt
1258861000
CY2020Q1 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
112910000
CY2019Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
126056000
CY2020Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1702593000
CY2019Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1479498000
CY2020Q1 us-gaap Liabilities
Liabilities
2254112000
CY2019Q2 us-gaap Liabilities
Liabilities
2035489000
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2019Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.004
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.004
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
186498704
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
144662470
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
185491064
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
143654830
CY2020Q1 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
579000
CY2019Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
575000
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1533905000
CY2019Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1511473000
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2711639000
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2436410000
CY2019Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
41836234
CY2020Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
41836234
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
232162000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
223993000
us-gaap Operating Expenses
OperatingExpenses
682001000
us-gaap Operating Expenses
OperatingExpenses
633452000
CY2020Q1 us-gaap Treasury Stock Value
TreasuryStockValue
1623256000
CY2019Q2 us-gaap Treasury Stock Value
TreasuryStockValue
1623256000
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-366436000
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-253009000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
2256431000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
2072193000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4510543000
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4107682000
CY2020Q1 us-gaap Revenues
Revenues
769455000
CY2019Q1 us-gaap Revenues
Revenues
662228000
us-gaap Revenues
Revenues
2186669000
us-gaap Revenues
Revenues
1901608000
CY2020Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
307657000
CY2019Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
270318000
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
880633000
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
782874000
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
12136000
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10940000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
37623000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
27095000
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
319793000
CY2019Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
281258000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
918256000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
809969000
CY2020Q1 us-gaap Gross Profit
GrossProfit
449662000
CY2019Q1 us-gaap Gross Profit
GrossProfit
380970000
us-gaap Gross Profit
GrossProfit
1268413000
us-gaap Gross Profit
GrossProfit
1091639000
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
172441000
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
164529000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
511304000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
473410000
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
51449000
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
47610000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
149425000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
129513000
CY2020Q1 rmd Amortization Of Acquired Intangible Assets1
AmortizationOfAcquiredIntangibleAssets1
8272000
CY2019Q1 rmd Amortization Of Acquired Intangible Assets1
AmortizationOfAcquiredIntangibleAssets1
11854000
rmd Amortization Of Acquired Intangible Assets1
AmortizationOfAcquiredIntangibleAssets1
21872000
rmd Amortization Of Acquired Intangible Assets1
AmortizationOfAcquiredIntangibleAssets1
24406000
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
-600000
rmd Acquisition Related Expenses
AcquisitionRelatedExpenses
6123000
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-4014000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
217500000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
156977000
us-gaap Operating Income Loss
OperatingIncomeLoss
586412000
us-gaap Operating Income Loss
OperatingIncomeLoss
458187000
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
116000
CY2019Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
415000
us-gaap Investment Income Interest
InvestmentIncomeInterest
766000
us-gaap Investment Income Interest
InvestmentIncomeInterest
2014000
CY2020Q1 us-gaap Interest Expense
InterestExpense
9968000
CY2019Q1 us-gaap Interest Expense
InterestExpense
12413000
us-gaap Interest Expense
InterestExpense
31180000
us-gaap Interest Expense
InterestExpense
23608000
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5295000
CY2019Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5996000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-19082000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-9371000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-10698000
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1054000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-15922000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4140000
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-25845000
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-19048000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-65418000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-35105000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
191655000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
137929000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
520994000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
423082000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28518000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
32513000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
77155000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
87291000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
163137000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
105416000
us-gaap Net Income Loss
NetIncomeLoss
443839000
us-gaap Net Income Loss
NetIncomeLoss
335791000
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.13
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.74
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.35
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.12
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.73
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.33
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.39
CY2019Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.37
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.17
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.11
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
144638000
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
143316000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
144112000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
142907000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
145680000
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
144333000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
145490000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
144344000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
163137000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
105416000
us-gaap Net Income Loss
NetIncomeLoss
443839000
us-gaap Net Income Loss
NetIncomeLoss
335791000
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-120318000
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2501000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-113427000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-28490000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
42819000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
102915000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
330412000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
307301000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
2072193000
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5609000
CY2019Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-327000
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
13256000
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-37576000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
120148000
CY2019Q3 us-gaap Dividends
Dividends
56052000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
2117251000
CY2019Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6498000
CY2019Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-40761000
CY2019Q4 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
12190000
CY2019Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
14057000
CY2019Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
44467000
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
160554000
CY2019Q4 us-gaap Dividends
Dividends
56150000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
2258106000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1816000
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
14112000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-120318000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
163137000
CY2020Q1 us-gaap Dividends
Dividends
56408000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
2256431000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
2058980000
CY2018Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
513000
CY2018Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-141000
CY2018Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
22845000
CY2018Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
12476000
CY2018Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-12872000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
105738000
CY2018Q3 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
-188799000
CY2018Q3 us-gaap Dividends
Dividends
52794000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
1900256000
CY2018Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1263000
CY2018Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-27341000
CY2018Q4 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
10576000
CY2018Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
12541000
CY2018Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-13117000
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
124639000
CY2018Q4 us-gaap Dividends
Dividends
52773000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
1956044000
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2896000
CY2019Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-330000
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
12828000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2501000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
105416000
CY2019Q1 us-gaap Dividends
Dividends
53024000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
2021329000
us-gaap Net Income Loss
NetIncomeLoss
443839000
us-gaap Net Income Loss
NetIncomeLoss
335791000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
116341000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
108203000
rmd Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
19524000
us-gaap Share Based Compensation
ShareBasedCompensation
41421000
us-gaap Share Based Compensation
ShareBasedCompensation
37856000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-19082000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-9371000
us-gaap Impairment Of Investments
ImpairmentOfInvestments
14519000
us-gaap Impairment Of Investments
ImpairmentOfInvestments
8801000
us-gaap Gain Loss On Sale Of Equity Investments
GainLossOnSaleOfEquityInvestments
1909000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-7000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-272000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
34140000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1482000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
22564000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
55002000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
68724000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
17453000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-57301000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-106671000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
471990000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
317233000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
77360000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
46507000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
7391000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
6556000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
27910000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
951565000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
31616000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
31092000
us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
32177000
us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
-3902000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-176454000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1031818000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
26112000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
15346000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
-45106000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
-27880000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
22844000
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
302000
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
648000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
990000000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1414230000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
883012000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
541394000
us-gaap Payments Of Dividends
PaymentsOfDividends
168610000
us-gaap Payments Of Dividends
PaymentsOfDividends
158592000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-80918000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
678218000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-8885000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-5821000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
205733000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-42188000
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
147128000
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
188701000
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
352861000
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
146513000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
150801000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
211816000
us-gaap Interest Paid Net
InterestPaidNet
31180000
us-gaap Interest Paid Net
InterestPaidNet
23608000
rmd Noncash Part Of Acquisition Fair Value Of Assets Acquired
NoncashPartOfAcquisitionFairValueOfAssetsAcquired
14922000
rmd Noncash Part Of Acquisition Fair Value Of Assets Acquired
NoncashPartOfAcquisitionFairValueOfAssetsAcquired
400804000
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
4294000
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
320923000
rmd Goodwill Acquired During Period Increase Decrease
GoodwillAcquiredDuringPeriodIncreaseDecrease
20550000
rmd Goodwill Acquired During Period Increase Decrease
GoodwillAcquiredDuringPeriodIncreaseDecrease
879419000
rmd Noncash Or Part Noncash Acquisition Deferred Payments
NoncashOrPartNoncashAcquisitionDeferredPayments
232000
rmd Noncash Or Part Noncash Acquisition Deferred Payments
NoncashOrPartNoncashAcquisitionDeferredPayments
-7568000
rmd Business Acquisition Contingent Consideration Recognized Liability
BusinessAcquisitionContingentConsiderationRecognizedLiability
3500000
rmd Business Acquisition Contingent Consideration Recognized Liability
BusinessAcquisitionContingentConsiderationRecognizedLiability
167000
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
27910000
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
951565000
CY2019Q2 rmd Lessee Operating Lease Estimated Discount Rate
LesseeOperatingLeaseEstimatedDiscountRate
0.035
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10940000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
27095000
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10940000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
27095000
CY2019Q1 us-gaap Gross Profit
GrossProfit
380970000
us-gaap Gross Profit
GrossProfit
1091639000
CY2020Q1 us-gaap Revenues
Revenues
769455000
CY2019Q1 us-gaap Revenues
Revenues
662228000
us-gaap Revenues
Revenues
2186669000
us-gaap Revenues
Revenues
1901608000
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
-600000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
6123000
CY2020Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
98885000
CY2019Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
80861000
CY2020Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2433000
CY2019Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2256000
CY2020Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
257454000
CY2019Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
266524000
CY2020Q1 us-gaap Inventory Net
InventoryNet
358772000
CY2019Q2 us-gaap Inventory Net
InventoryNet
349641000
CY2020Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
903299000
CY2019Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
898975000
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
506090000
CY2019Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
511515000
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
397209000
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
387460000
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
464963000
CY2019Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
521950000
CY2019Q2 us-gaap Goodwill
Goodwill
1856449000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
20550000
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
16808000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-9349000
CY2020Q1 us-gaap Goodwill
Goodwill
1884458000
us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
5000000
CY2020Q1 us-gaap Investments
Investments
50118000
CY2019Q1 us-gaap Investments
Investments
49146000
CY2019Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1262000000
CY2020Q1 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
4151000
CY2019Q2 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
3139000
CY2020Q1 us-gaap Long Term Debt
LongTermDebt
1364849000
CY2019Q2 us-gaap Long Term Debt
LongTermDebt
1258861000
CY2020Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1376836000
CY2019Q2 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1270853000
rmd Debt To Consolidated Ebitda Ratio
DebtToConsolidatedEbitdaRatio
3.50
CY2020Q1 us-gaap Senior Notes
SeniorNotes
500000000.0
CY2020Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
7200000
us-gaap Operating Lease Cost
OperatingLeaseCost
19600000
CY2019Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
19625000
CY2018Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
19227000
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
10879000
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
11601000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
9620000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
10790000
us-gaap Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
1650000
us-gaap Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
405000
CY2020Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
19234000
CY2019Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
19633000
CY2020Q1 rmd Short Term Borrowings Gross
ShortTermBorrowingsGross
12000000
CY2019Q2 rmd Short Term Borrowings Gross
ShortTermBorrowingsGross
12012000
CY2020Q1 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
13000
CY2019Q2 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
20000
CY2020Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
11987000
CY2019Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
11992000
CY2020Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1369000000
CY2020Q1 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
9478000
CY2020Q1 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
7916000
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
126277000
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
22795000
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
107251000
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
130046000
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0307
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
150844000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
7098000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
24744000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
18349000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
14921000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
12178000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
10560000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
62994000
CY2020Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
20798000
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
130046000
CY2020Q1 rmd Lessee Operating Lease Lease Not Yet Commenced Commitments
LesseeOperatingLeaseLeaseNotYetCommencedCommitments
14000000.0
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
23400000
CY2018 us-gaap Operating Lease Cost
OperatingLeaseCost
21100000
CY2017 us-gaap Operating Lease Cost
OperatingLeaseCost
20100000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
87.45
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y7M6D
CY2020Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
146.34
CY2020Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
724040
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
70.70
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
137000
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
129000
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
267556000
CY2020Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
98013000
CY2020Q1 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
23500000
CY2020Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
17161000
CY2020Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
12403000
CY2020Q1 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
27555000
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
6301000
us-gaap Operating Lease Payments
OperatingLeasePayments
17352000
CY2020Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
34876000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
51573000
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
41800000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1600000000
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
200000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
22800000
CY2020Q1 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
12900000
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1260114
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
72.91
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y4M24D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
162180
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
146.34
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
260666
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
53.41
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
4342
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
110.19
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1157286
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
356583000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
128789
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
161314
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
163137000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
105416000
us-gaap Net Income Loss
NetIncomeLoss
443839000
us-gaap Net Income Loss
NetIncomeLoss
335791000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
144638000
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
143316000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
144112000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
142907000
CY2020Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1042000
CY2019Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1017000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1378000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1437000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
145680000
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
144333000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
145490000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
144344000
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.13
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.74
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.35
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.12
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.73
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.33
rmd Receivables Sold Amount
ReceivablesSoldAmount
99785000
rmd Receivables Sold Amount
ReceivablesSoldAmount
99693000
CY2020Q1 us-gaap Guarantee Obligations Maximum Exposure
GuaranteeObligationsMaximumExposure
25306000
CY2019Q2 us-gaap Guarantee Obligations Maximum Exposure
GuaranteeObligationsMaximumExposure
29450000
CY2020Q1 rmd Provision For Doubtful Debts
ProvisionForDoubtfulDebts
4764000
CY2019Q2 rmd Provision For Doubtful Debts
ProvisionForDoubtfulDebts
1752000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
6100000

Files In Submission

Name View Source Status
0000943819-20-000008-index-headers.html Edgar Link pending
0000943819-20-000008-index.html Edgar Link pending
0000943819-20-000008.txt Edgar Link pending
0000943819-20-000008-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rmd-20200331.xsd Edgar Link pending
rmd-20200331x10q.htm Edgar Link pending
rmd-20200331x10q_htm.xml Edgar Link completed
rmd-20200331xex31_1.htm Edgar Link pending
rmd-20200331xex31_2.htm Edgar Link pending
rmd-20200331xex32.htm Edgar Link pending
rmd-20200331_cal.xml Edgar Link unprocessable
rmd-20200331_def.xml Edgar Link unprocessable
rmd-20200331_lab.xml Edgar Link unprocessable
rmd-20200331_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending